Skip to main content

Table 5 Substance use over prior 30 days

From: White matter deficits assessed by diffusion tensor imaging and cognitive dysfunction in psychostimulant users with comorbid human immunodeficiency virus infection

 

Controls (n = 22)

Patients (n = 21)

Alcohol (# using)

16

7**

Alcohol (# days) [4.2 ± 3.7 units]

4.6 ± 5.7

2.4 ± 6.5

Heroin (# using)

0

7**

Heroin (# days) [0.2 ± 0.15 g]

0

3.4 ± 7.9*

Cocaine powder (# using)

2

13**

Cocaine powder (# days) [0.52 ± 0.76 g]

1

9.4 ± 12.1**

Crack cocaine (# using)

0

19**

Crack cocaine (# days) [0.92 ± 1.65 g]

0

18.3 ± 12.3**

Amphetamines (# using)

0

6**

Amphetamines (# days) [0.38 ± 0.40 g]

0

4.0 ± 8.6*

Cannabis (# using)

4

13**

Cannabis (# days) [0.95 ± 0.68 g]

1.6 ± 5.6

14.3 ± 13.9**

  1. Numbers indicate either number of subjects per group using the drug (# using) or mean number of days per 30 days spent using the drug (# days) ± SEM. Significant difference between groups * p < 0.05, ** p < 0.01. For number of days using each drug, mean daily intake (± SEM) for both groups for cases who used the drug is included in square parentheses